Alternative to CBD? Beraca to launch Amazonian oil complex to fight stress and aging
21 Feb 2020 --- At a time when cannabidiol (CBD) enjoys market prominence for its therapeutic qualities, but is widely limited by regulation – Brazillian company Beraca introduces an “natural and safe alternative” to the cannabis extract. Beracare CBA (Cannabinoid Active System) is a complex of Amazonian oils marketed as reducing inflammatory activity while stimulating the production of beneficial β-endorphins. Moreover, the company targets the launch of its Açai Extract, further tapping into the graceful aging trend.
“Beraca develops products in a way that is sustainable and ethical while measuring its direct impact on nature and society. Beracare CBA, in addition to being developed within these guidelines, is an avant-garde active compound because it aims to answer the current consumers’ demand, who increasingly seek beauty products for mindfulness. Beracare CBA has well-being and stress-relieving properties, promoting several benefits to the skin, such as a feeling of relaxation, improvement in healing activity and overall comfort,” explains Daniel Sabará, CEO of Beraca.
Beraca is also set to debut its new Açaí Extract ingredient on the international market. Beracare CBA is the first of two products to be launched by Beraca at the upcoming in-cosmetics Global 2020 expo (March 31 to April 2) held in Barcelona, Spain. The complex of Amazon oils contain high levels of terpenes and unsaturated fatty acids, such as linoleic acid, in particular. This is noted as an important component related to the increase in skin’s permeability, improving the efficacy of the active.
The company is also set to debut its new Açaí Extract ingredient on the international market. The product is marketed as additive-free and is made from sustainably sourced açaí berries native to the Amazon region. This particular ingredient is hailed for having the ability to mitigate wrinkle formation, improve the skin’s vitality and glow, protect and repair against external aggressions, in addition to being a powerful antioxidant.
“Our launch fits into the worldwide concept of ageing with quality. The term anti-aging is giving way to the pro-aging movement, where people realize that there is no reason to condemn the advancement of age, but rather to embrace it in the best possible way. Beraca’s Açaí Extract enhances the pro-aging trend because it is a powerful antioxidant, proven through efficacy tests, which also revealed excellent anti-glycation and anti-pollution results,” explains Marianna Cyrillo, Marketing Manager at Beraca.
CBD market faces regulatory headwinds
The globally booming CBD market is still facing regulatory hurdles. “Without a uniform federal regulatory framework in place, consumers lack the basic information they need to make informed decisions about CBD,” Geoff Freeman, Grocery Manufacturers Association (GMA) President and CEO, previously told NutritionInsight.
Earlier this month, US President Donald Trump requested US$5 million, from the FY2021 budget, to regulate the CBD industry to allow the Food and Drug Administration (FDA) to continue enforcing protection laws safeguarding patients and consumers.
Meanwhile, the UK Food Standards Agency (FSA) set a deadline for CBD companies to provide more information about their products and their contents. The government gives industry by March 31, 2021, to submit valid novel food authorization applications. Beyond that date, only products with a valid application will be allowed to remain on the market.
In light of policy challenges, alternatives for the cannabis extract have been attracting interest. Last May, a synthetic, non-intoxicating CBD alternative, 8,9-Dihydrocannabidiol (H2CBD) was found to be as effective in treating the frequency and severity of seizures in rats, pointing towards a potential therapeutic application for humans.
Next April, during the 12th Cosmetic Compliance Spring 2020 Summit, in New York, US, federal and state lawmakers and regular affairs specialists from both big and independent cosmetic brands are set to discuss practical strategies to remain compliant in a constantly changing regulatory landscape.
By Benjamin Ferrer
